These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17434018)

  • 1. Safety and acceptability with the use of a contraceptive vaginal ring after surgical or medical abortion.
    Fine PM; Tryggestad J; Meyers NJ; Sangi-Haghpeykar H
    Contraception; 2007 May; 75(5):367-71. PubMed ID: 17434018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive.
    Schafer JE; Osborne LM; Davis AR; Westhoff C
    Contraception; 2006 May; 73(5):488-92. PubMed ID: 16627032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraception after medical abortion.
    Mittal S
    Contraception; 2006 Jul; 74(1):56-60. PubMed ID: 16781262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot safety and tolerability study of a nonhormonal vaginal contraceptive ring.
    Del Priore G; Malanowska-Stega J; Shalaby SW; Richman S
    J Reprod Med; 2009; 54(11-12):685-90. PubMed ID: 20120902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers associated with the failure to return for intrauterine device insertion following first-trimester abortion.
    Stanek AM; Bednarek PH; Nichols MD; Jensen JT; Edelman AB
    Contraception; 2009 Mar; 79(3):216-20. PubMed ID: 19185676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of "observed start" vs. traditional "Sunday start" on hormonal contraceptive continuation rates after medical abortion.
    Bednarek PH; Nichols MD; Carlson N; Edelman AB; Creinin MD; Truitt S; Jensen JT
    Contraception; 2008 Jul; 78(1):26-30. PubMed ID: 18555814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High acceptability and satisfaction with NuvaRing use.
    Szarewski A
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():31-6; discussion 37-9. PubMed ID: 12659400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine follow-up visits after first-trimester induced abortion.
    Grossman D; Ellertson C; Grimes DA; Walker D
    Obstet Gynecol; 2004 Apr; 103(4):738-45. PubMed ID: 15051567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing.
    Bruni V; Pontello V; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):65-71. PubMed ID: 18358586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multinational evaluation of the efficacy, safety and acceptability of the Protectaid contraceptive sponge.
    Creatsas G; Guerrero E; Guilbert E; Drouin J; Serfaty D; Lemieux L; Suissa S; Colin P
    Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):172-82. PubMed ID: 11763982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial.
    Sivin I; Mishell DR; Alvarez F; Brache V; Elomaa K; Lähteenmäki P; Massai R; Miranda P; Croxatto H; Dean C; Small M; Nash H; Jackanicz TM
    Contraception; 2005 Feb; 71(2):122-9. PubMed ID: 15707562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended regimens of the contraceptive vaginal ring: a randomized trial.
    Miller L; Verhoeven CH; Hout Ji
    Obstet Gynecol; 2005 Sep; 106(3):473-82. PubMed ID: 16135576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands.
    Roumen FJ; op ten Berg MM; Hoomans EH
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):14-22. PubMed ID: 16546812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing: results of clinical experience in Germany.
    Brucker C; Karck U; Merkle E
    Eur J Contracept Reprod Health Care; 2008 Mar; 13(1):31-8. PubMed ID: 17853162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion of intrauterine contraceptives immediately following first- and second-trimester abortions.
    Drey EA; Reeves MF; Ogawa DD; Sokoloff A; Darney PD; Steinauer JE
    Contraception; 2009 May; 79(5):397-402. PubMed ID: 19341854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing patient telephone callback rates for different hormonal birth control delivery systems.
    Victor I; Fink RA
    Am J Ther; 2006; 13(6):507-12. PubMed ID: 17122531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials.
    Roumen FJ
    Contraception; 2007 Jun; 75(6):420-9. PubMed ID: 17519147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncomparative contraceptive efficacy of cellulose sulfate gel.
    Mauck CK; Freziers RG; Walsh TL; Peacock K; Schwartz JL; Callahan MM
    Obstet Gynecol; 2008 Mar; 111(3):739-46. PubMed ID: 18310379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa.
    Dao B; Blum J; Thieba B; Raghavan S; Ouedraego M; Lankoande J; Winikoff B
    BJOG; 2007 Nov; 114(11):1368-75. PubMed ID: 17803715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.